KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (Diluted Average) (2016 - 2025)

Pacira BioSciences has reported Shares Outstanding (Diluted Average) over the past 16 years, most recently at $45.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $45.0 million for Q4 2025, down 2.6% from a year ago — trailing twelve months through Dec 2025 was $45.0 million (down 2.6% YoY), and the annual figure for FY2025 was $45.0 million, down 2.6%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $45.0 million at Pacira BioSciences, up from $44.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PCRX hit a ceiling of $52.3 million in Q2 2022 and a floor of $44.5 million in Q3 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $46.3 million (2023), compared with a mean of $47.7 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 14.33% in 2022 and later decreased 11.44% in 2023.
  • Pacira BioSciences' Shares Outstanding (Diluted Average) stood at $45.6 million in 2021, then grew by 1.99% to $46.5 million in 2022, then increased by 11.69% to $52.0 million in 2023, then fell by 11.03% to $46.2 million in 2024, then fell by 2.6% to $45.0 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $45.0 million (Q4 2025), $44.5 million (Q3 2025), and $45.9 million (Q2 2025) per Business Quant data.